Roth Capital Partners is acting as the Company's financial advisor for this transaction.
Organovo is a clinical stage biotechnology company that is developing drugs that are demonstrated to be effective in three-dimensional (3D) human tissues as candidates for drug development. The ...
Occidental announced an offer to exercise its outstanding publicly traded warrants at a temporarily reduced price. The Offer is available to ...
United Lithium Corp. (“United Lithium” or the “Company”) (CSE: ULTH; OTCQX: ULTHF; FWB: 0UL) is announcing that it has applied to ...
Prior to completion of the transaction, Kinross held 5,100,000 Shares, representing approximately 6.8% of the issued and outstanding Shares, and 2,550,000 Share purchase warrants of Relevant Gold (the ...
ASHKELON, ISRAEL and VANCOUVER, BRITISH COLUMBIA - February 28, 2025 (NEWMEDIAWIRE) - Femto Technologies Inc. (Nasdaq: FMTO) ...
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA ...
Metals (TSX-V:QTWO) has raised C$7.6 million ($8.5 million) after shareholders exercised share purchase warrants before they ...
Cosa Resources is a Canadian uranium exploration company operating in northern Saskatchewan. The portfolio comprises roughly 237,000 ha across multiple 100% owned and Cosa operated Joint Venture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results